Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,824 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey.
Shiraki M, Kadowaki S, Miwa Y, Nishimura K, Maruyama Y, Kishida D, Imagawa K, Kobayashi C, Takada H, Mitsunaga K, Inoue Y, Ebato T, Miyamoto T, Hiejima E, Sato S, Migita K, Matsubayashi T, Kobayashi D, Hasegawa E, Kaneko U, Ishikawa T, Onodera M, Matsushita K, Koike Y, Umebayashi H, Kakuta F, Abukawa D, Funakoshi Y, Ishimura M, Otani Y, Nishizawa T, Ishige T, Hatori R, Tanaka S, Kusunoki S, Nakamura K, Shirai H, Hatai Y, Miyaoka F, Kaneko S, Shimbo A, Shimizu M, Kanegane H, Hashimoto M, Negoro N, Yoshida T, Wada Y, Usami M, Wada T, Izawa K, Yasumi T, Nishikomori R, Ohnishi H. Shiraki M, et al. Among authors: hashimoto m. Front Immunol. 2025 Jun 12;16:1548042. doi: 10.3389/fimmu.2025.1548042. eCollection 2025. Front Immunol. 2025. PMID: 40574834 Free PMC article.
Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.
Yamasaki Y, Kobayashi N, Akioka S, Yamazaki K, Takezaki S, Nakaseko H, Ohara A, Nishimura K, Nishida Y, Sato S, Kishi T, Hashimoto M, Mori M, Okazaki Y, Kuwana M, Ohta A. Yamasaki Y, et al. Among authors: hashimoto m. Rheumatology (Oxford). 2021 Oct 2;60(10):4821-4831. doi: 10.1093/rheumatology/keab108. Rheumatology (Oxford). 2021. PMID: 33576399
Increased Ratio of CD14++CD80+ Cells/CD14++CD163+ Cells in the Infrapatellar Fat Pad of End-Stage Arthropathy Patients.
Ma S, Murakami K, Saito R, Ito H, Murata K, Nishitani K, Hashimoto M, Tanaka M, Taniguchi M, Kitagori K, Akizuki S, Nakashima R, Yoshifuji H, Ohmura K, Morinobu A, Mimori T. Ma S, et al. Among authors: hashimoto m. Front Immunol. 2021 Nov 26;12:774177. doi: 10.3389/fimmu.2021.774177. eCollection 2021. Front Immunol. 2021. PMID: 34899727 Free PMC article.
ECG Changes Through Immunosuppressive Therapy Indicate Cardiac Abnormality in Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis.
Matsuo T, Sasai T, Nakashima R, Kuwabara Y, Kato ET, Murakami I, Onizawa H, Akizuki S, Murakami K, Hashimoto M, Yoshifuji H, Tanaka M, Morinobu A, Mimori T. Matsuo T, et al. Among authors: hashimoto m. Front Immunol. 2022 Jan 7;12:765140. doi: 10.3389/fimmu.2021.765140. eCollection 2021. Front Immunol. 2022. PMID: 35069538 Free PMC article. Clinical Trial.
Perspectives of JAK Inhibitors for Large Vessel Vasculitis.
Watanabe R, Hashimoto M. Watanabe R, et al. Among authors: hashimoto m. Front Immunol. 2022 Mar 30;13:881705. doi: 10.3389/fimmu.2022.881705. eCollection 2022. Front Immunol. 2022. PMID: 35432355 Free PMC article. Review.
Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis.
Iwasaki T, Watanabe R, Ito H, Fujii T, Okuma K, Oku T, Hirayama Y, Ohmura K, Murata K, Murakami K, Yoshitomi H, Tanaka M, Matsuda S, Matsuda F, Morinobu A, Hashimoto M. Iwasaki T, et al. Among authors: hashimoto m. Front Immunol. 2022 Jun 6;13:901437. doi: 10.3389/fimmu.2022.901437. eCollection 2022. Front Immunol. 2022. PMID: 35734167 Free PMC article.
Vasculitogenic T Cells in Large Vessel Vasculitis.
Watanabe R, Hashimoto M. Watanabe R, et al. Among authors: hashimoto m. Front Immunol. 2022 Jun 15;13:923582. doi: 10.3389/fimmu.2022.923582. eCollection 2022. Front Immunol. 2022. PMID: 35784327 Free PMC article. Review.
Long-term efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: a propensity score matching analysis in the multicenter REVEAL cohort study.
Shiomi M, Watanabe R, Matsuda S, Kotani T, Okazaki A, Masuda Y, Yoshida T, Shoji M, Tsuge R, Kadoba K, Hiwa R, Yamamoto W, Takeda A, Itoh Y, Hashimoto M. Shiomi M, et al. Among authors: hashimoto m. Front Immunol. 2024 Oct 2;15:1457202. doi: 10.3389/fimmu.2024.1457202. eCollection 2024. Front Immunol. 2024. PMID: 39416779 Free PMC article.
4,824 results